Volume 28, Number 1—January 2022
Synopsis
Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018–2019
Table 1
Characteristics for 38 confirmed and probable case-patients who had Verona integron‒encoded, metallo-β-lactamase‒producing Pseudomonas aeruginosa among US medical tourists traveling to Tijuana, Mexico, January 2018–December 2019
Characteristic | No. (%) |
---|---|
Age, y | |
23–34 | 14 (37) |
35–49 | 15 (40) |
50–64 | 6 (16) |
≥65 | 1 (3) |
Unknown |
2 (5) |
Sex | |
F | 34 (90) |
M |
4 (10) |
Surgical facility | |
Facility A | 27 (71) |
Facility B | 1 (3) |
Facility C | 1 (3) |
Facility D | 1 (3) |
Facility E* | 2 (5) |
Facility F | 1 (3) |
Facility G | 1 (3) |
Facility H | 1 (3) |
Facility I | 2 (5) |
Facility J | 1 (3) |
Unknown |
1 (3) |
Surgeon who performed procedure | |
Surgeon 1 | 31 (82) |
Surgeon 2 | 1 (3) |
Surgeon 3 | 1 (3) |
Surgeon 4 | 1 (3) |
Surgeon 5 | 1 (3) |
Unknown |
3 (8) |
Surgical procedure† | |
Sleeve gastrectomy | 34 (90) |
Cholecystectomy | 1 (3) |
Laparoscopic adjustable gastric band | 1 (3) |
Sleeve gastrectomy revision | 1 (3) |
Unspecified bariatric surgery |
3 (8) |
Specimen source | |
Wound | 31 (82) |
Intraabdominal abscess | 4 (11) |
Abdominal fluid | 1 (3) |
Blood | 1 (3) |
Rectal swab specimen |
1 (3) |
Hospitalized in the United States after surgery | 16 (42) |
Patient died within 30 d of specimen collection | 1 (3) |
*Patient reported exposure to facilities E and D. †Four patients underwent >1 procedure: gastrectomy and cholecystectomy (n = 1), sleeve gastrectomy and bowel resection (1), sleeve gastrectomy and lap band removal (1), and sleeve gastrectomy, breast augmentation, and abdominoplasty (1).
1These authors contributed equally to this article.
2Members of this team are listed at the end of this article.